APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.12%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.58B
AUM Growth
+$3.58B
(+20%)
Cap. Flow
+$540M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
131
New
36
Increased
33
Reduced
15
Closed
37
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$103M |
| 2 |
Medtronic
MDT
|
$85.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$80.2M |
| 4 |
Nuvation Bio
NUVB
|
$78.6M |
| 5 |
AbbVie
ABBV
|
$78M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$137M |
| 2 |
Quest Diagnostics
DGX
|
$94.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$87.1M |
| 4 |
Organogenesis Holdings
ORGO
|
$73.9M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$57.5M |
Sector Composition
| 1 | Healthcare | 96.26% |
| 2 | Financials | 0.29% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$372B
| $225M | 6.21% | 2,077,200 +721,200 | +53% | +$78M |
|
2
AstraZeneca
AZN
$248B
| $182M | 5.01% | 3,650,500 +1,350,500 | +59% | +$67.1M |
|
3
Avantor
AVTR
$9.18B
| $144M | 3.98% | 4,985,100 -1,581,600 | -24% | -$45.8M |
|
|
4
Medtronic
MDT
$119B
| $121M | 3.34% | 1,024,200 +723,200 | +240% | +$85.4M |
|
5
Arvinas
ARVN
$568M
| $116M | 3.21% | 1,760,300 -27,058 | -2% | -$1.79M |
|
|
6
Intuitive Surgical
ISRG
$170B
| $103M | 2.85% | +139,400 | New | +$103M |
|
7
Maravai LifeSciences
MRVI
$350M
| $98.4M | 2.72% | 2,761,545 -684,227 | -20% | -$24.4M |
|
8
Cardinal Health
CAH
$35.5B
| $88.9M | 2.46% | 1,463,000 +655,000 | +81% | +$39.8M |
|
9
Syndax Pharmaceuticals
SNDX
$1.41B
| $86M | 2.38% | 3,846,000 +538,000 | +16% | +$12M |
|
10
ESSA Pharma
EPIX
$11.4M
| $82.5M | 2.28% | 2,840,000 +282,000 | +11% | +$8.19M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $81.5M | 2.25% | 475,700 +95,700 | +25% | +$16.4M |
|
|
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
| $80.2M | 2.22% | +577,900 | New | +$80.2M |
|
13
Exact Sciences
EXAS
$8.98B
| $78.8M | 2.18% | 598,000 +351,000 | +142% | +$46.3M |
|
|
14
Nuvation Bio
NUVB
$1.02B
| $78.6M | 2.17% | +7,521,941 | New | +$78.6M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $71.8M | 1.98% | 1,049,800 +558,000 | +113% | +$38.1M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $66.8M | 1.85% | 310,900 +163,600 | +111% | +$35.2M |
|
|
IMAB
17
I-MAB
IMAB
$340M
| $64.4M | 1.78% | 1,329,000 -262,000 | -16% | -$12.7M |
|
|
ARNA
18
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $62.4M | 1.72% | 898,550 +277,550 | +45% | +$19.3M |
|
19
Alnylam Pharmaceuticals
ALNY
$58.5B
| $60.4M | 1.67% | +427,969 | New | +$60.4M |
|
20
Bausch Health
BHC
$2.74B
| $60M | 1.66% | 1,891,300 -80,700 | -4% | -$2.56M |
|
|
CTLT
21
DELISTED
CATALENT, INC.
CTLT
| $59M | 1.63% | 560,000 +223,000 | +66% | +$23.5M |
|
22
Zentalis Pharmaceuticals
ZNTL
$122M
| $54.8M | 1.51% | 1,263,300 +128,300 | +11% | +$5.57M |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $53.5M | 1.48% | 581,000 -588,300 | -50% | -$54.1M |
|
|
BPMC
24
DELISTED
Blueprint Medicines
BPMC
| $53.1M | 1.47% | 546,000 +306,000 | +128% | +$29.8M |
|
25
Zimmer Biomet
ZBH
$21B
| $52.2M | 1.44% | +326,000 | New | +$52.2M |
|